Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$15.38 - $20.2 $510,616 - $670,640
-33,200 Reduced 67.76%
15,800 $319,000
Q2 2025

Aug 14, 2025

BUY
$12.82 - $18.15 $628,180 - $889,349
49,000 New
49,000 $821,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.